Medtronic plcMDT announced that the FDA has approved a new arm indication for the Guardian Sensor 3 continuous glucose monitor (CGM) used with the MiniMed 670G insulin pump. Notably, the Guardian ...

The FDA has expanded its indication for Medtronic’s Guardian Sensor 3, allowing patients to wear the sensor on their upper arm. The sensor is part of Medtronic’s MiniMed 670G system, and is currently ...

DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of ...

New No Fingerstick 1 Sensor Integrates with Both the MiniMed 780G System and the Smart InPen System DUBLIN, May 26, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical ...

* MEDTRONIC RECEIVES FDA APPROVAL FOR NEW ARM INDICATION FOR GUARDIAN SENSOR 3 - FURTHER ENHANCING THE MINIMED 670G HYBRID CLOSED LOOP EXPERIENCE Source text for Eikon: Further company coverage: Sign ...

Medtronic has finally received FDA clearance for Guardian Connect, its smartphone-connected standalone CGM for patients who use multiple daily injections (MDI) for their insulin. Medtronic's ...

Knoxville-area mom Crystal had always been diligent with the health of her two sons. Now teens, they’re both active with hearty, and mostly healthy, appetites. So when her younger son, Landyn, was ...

Medtronic is teaming up with the diabetes data nonprofit outfit Tidepool to create a new, interoperable version of its MiniMed insulin pump—and in return, the medtech giant will help Tidepool work to ...

It’s notoriously difficult to manage blood sugar levels in children and teenagers with Type 1 diabetes because of their high activity levels, constantly fluctuating hormones and ongoing growth and ...

Please provide your email address to receive an email when new articles are posted on . Children with type 1 diabetes who used an advanced hybrid closed-loop insulin delivery system for 1 year ...